Quarterly Report (10-q)

false--12-31Q22019000115886312000000.0010.0011000000000100000000040333000403500003985300039870000P1YP6MP1YP1Y00004800004800002 0001158863 2019-01-01 2019-06-30 0001158863 2019-08-02 0001158863 2019-06-30 0001158863 2018-12-31 0001158863 2018-01-01 2018-06-30 0001158863 2019-04-01 2019-06-30 0001158863 wage:OtherProductsandServicesMember 2019-04-01 2019-06-30 0001158863 2018-04-01 2018-06-30 0001158863 wage:OtherProductsandServicesMember 2018-04-01 2018-06-30 0001158863 wage:COBRAMember 2019-04-01 2019-06-30 0001158863 wage:CommuterMember 2019-01-01 2019-06-30 0001158863 wage:CommuterMember 2018-04-01 2018-06-30 0001158863 wage:COBRAMember 2018-01-01 2018-06-30 0001158863 wage:OtherProductsandServicesMember 2019-01-01 2019-06-30 0001158863 us-gaap:HealthCareMember 2019-01-01 2019-06-30 0001158863 us-gaap:HealthCareMember 2018-04-01 2018-06-30 0001158863 us-gaap:HealthCareMember 2019-04-01 2019-06-30 0001158863 us-gaap:HealthCareMember 2018-01-01 2018-06-30 0001158863 wage:CommuterMember 2019-04-01 2019-06-30 0001158863 wage:COBRAMember 2018-04-01 2018-06-30 0001158863 wage:CommuterMember 2018-01-01 2018-06-30 0001158863 wage:OtherProductsandServicesMember 2018-01-01 2018-06-30 0001158863 wage:COBRAMember 2019-01-01 2019-06-30 0001158863 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001158863 us-gaap:RetainedEarningsMember 2018-12-31 0001158863 us-gaap:CommonStockMember 2019-03-31 0001158863 2019-01-01 2019-03-31 0001158863 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001158863 us-gaap:TreasuryStockMember 2019-03-31 0001158863 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001158863 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001158863 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001158863 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001158863 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001158863 us-gaap:TreasuryStockMember 2018-12-31 0001158863 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001158863 2019-03-31 0001158863 us-gaap:CommonStockMember 2018-12-31 0001158863 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001158863 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001158863 us-gaap:RetainedEarningsMember 2019-03-31 0001158863 us-gaap:CommonStockMember 2019-06-30 0001158863 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001158863 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001158863 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001158863 us-gaap:TreasuryStockMember 2019-06-30 0001158863 us-gaap:RetainedEarningsMember 2019-06-30 0001158863 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001158863 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001158863 us-gaap:TreasuryStockMember 2018-06-30 0001158863 2018-01-01 0001158863 us-gaap:CommonStockMember 2017-12-31 0001158863 2018-01-01 2018-03-31 0001158863 us-gaap:TreasuryStockMember 2018-03-31 0001158863 us-gaap:CommonStockMember 2018-03-31 0001158863 us-gaap:CommonStockMember 2018-06-30 0001158863 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001158863 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001158863 2018-06-30 0001158863 us-gaap:RetainedEarningsMember 2018-06-30 0001158863 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001158863 us-gaap:TreasuryStockMember 2017-12-31 0001158863 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001158863 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001158863 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001158863 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0001158863 2018-03-31 0001158863 us-gaap:RetainedEarningsMember 2017-12-31 0001158863 2017-12-31 0001158863 us-gaap:RetainedEarningsMember 2018-03-31 0001158863 us-gaap:RetainedEarningsMember 2018-01-01 0001158863 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001158863 wage:HealthEquityInc.Member 2019-01-01 2019-06-30 0001158863 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001158863 wage:HealthEquityInc.Member wage:WageWorksInc.Member 2019-06-26 0001158863 wage:StockOptionsAndRestrictedStockUnitsMember 2018-04-01 2018-06-30 0001158863 wage:StockOptionsAndRestrictedStockUnitsMember 2018-01-01 2018-06-30 0001158863 wage:StockOptionsAndRestrictedStockUnitsMember 2019-01-01 2019-06-30 0001158863 wage:StockOptionsAndRestrictedStockUnitsMember 2019-04-01 2019-06-30 0001158863 wage:InterchangeMember 2019-04-01 2019-06-30 0001158863 wage:BenefitAdministrationServiceAndCOBRAMember 2018-01-01 2018-06-30 0001158863 wage:OtherRevenueMember 2018-01-01 2018-06-30 0001158863 wage:BenefitAdministrationServiceAndCOBRAMember 2019-01-01 2019-06-30 0001158863 wage:InterchangeMember 2019-01-01 2019-06-30 0001158863 wage:InterchangeMember 2018-01-01 2018-06-30 0001158863 wage:OtherRevenueMember 2019-01-01 2019-06-30 0001158863 wage:BenefitAdministrationServiceAndCOBRAMember 2019-04-01 2019-06-30 0001158863 wage:InterchangeMember 2018-04-01 2018-06-30 0001158863 wage:BenefitAdministrationServiceAndCOBRAMember 2018-04-01 2018-06-30 0001158863 wage:OtherRevenueMember 2019-04-01 2019-06-30 0001158863 wage:OtherRevenueMember 2018-04-01 2018-06-30 0001158863 2022-01-01 2019-06-30 0001158863 2021-01-01 2019-06-30 0001158863 2020-01-01 2019-06-30 0001158863 2019-04-01 2019-06-30 0001158863 us-gaap:MunicipalBondsMember 2018-12-31 0001158863 us-gaap:MoneyMarketFundsMember 2018-12-31 0001158863 us-gaap:MunicipalBondsMember 2018-12-31 0001158863 us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0001158863 us-gaap:CommercialPaperMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel1Member wage:NonU.S.GovernmentandAgencySecuritiesMember 2018-12-31 0001158863 us-gaap:CertificatesOfDepositMember 2018-12-31 0001158863 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001158863 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2018-12-31 0001158863 wage:NonU.S.GovernmentandAgencySecuritiesMember 2018-12-31 0001158863 us-gaap:USGovernmentDebtSecuritiesMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2018-12-31 0001158863 us-gaap:CashEquivalentsMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001158863 us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001158863 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member 2018-12-31 0001158863 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0001158863 us-gaap:CashEquivalentsMember 2018-12-31 0001158863 us-gaap:CashEquivalentsMember us-gaap:FairValueInputsLevel1Member 2018-12-31 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentDebtSecuritiesMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentDebtSecuritiesMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001158863 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel1Member 2018-12-31 0001158863 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel2Member 2018-12-31 0001158863 us-gaap:MunicipalBondsMember us-gaap:FairValueInputsLevel1Member 2018-12-31 0001158863 us-gaap:FairValueInputsLevel2Member wage:NonU.S.GovernmentandAgencySecuritiesMember 2018-12-31 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember 2018-12-31 0001158863 us-gaap:MunicipalBondsMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001158863 us-gaap:AssetBackedSecuritiesMember us-gaap:ShortTermInvestmentsMember 2019-06-30 0001158863 us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember us-gaap:ShortTermInvestmentsMember 2019-06-30 0001158863 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ShortTermInvestmentsMember 2019-06-30 0001158863 wage:CashEquivalentsAndShortTermInvestmentsMember 2019-06-30 0001158863 us-gaap:ShortTermInvestmentsMember 2019-06-30 0001158863 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:ShortTermInvestmentsMember 2019-06-30 0001158863 us-gaap:CorporateDebtSecuritiesMember us-gaap:ShortTermInvestmentsMember 2019-06-30 0001158863 us-gaap:CashEquivalentsMember us-gaap:CashAndCashEquivalentsMember 2019-06-30 0001158863 us-gaap:CommercialPaperMember us-gaap:CashAndCashEquivalentsMember 2019-06-30 0001158863 us-gaap:ShortTermInvestmentsMember 2018-12-31 0001158863 us-gaap:CorporateDebtSecuritiesMember us-gaap:ShortTermInvestmentsMember 2018-12-31 0001158863 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:ShortTermInvestmentsMember 2018-12-31 0001158863 us-gaap:AssetBackedSecuritiesMember us-gaap:ShortTermInvestmentsMember 2018-12-31 0001158863 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ShortTermInvestmentsMember 2018-12-31 0001158863 wage:NonU.S.GovernmentandAgencySecuritiesMember us-gaap:ShortTermInvestmentsMember 2018-12-31 0001158863 us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember us-gaap:ShortTermInvestmentsMember 2018-12-31 0001158863 us-gaap:MunicipalBondsMember us-gaap:ShortTermInvestmentsMember 2018-12-31 0001158863 us-gaap:MunicipalBondsMember 2019-06-30 0001158863 us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2019-06-30 0001158863 us-gaap:MoneyMarketFundsMember 2019-06-30 0001158863 us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2019-06-30 0001158863 us-gaap:MunicipalBondsMember 2019-06-30 0001158863 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member 2019-06-30 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-06-30 0001158863 us-gaap:USGovernmentDebtSecuritiesMember 2019-06-30 0001158863 us-gaap:CommercialPaperMember 2019-06-30 0001158863 us-gaap:CashEquivalentsMember 2019-06-30 0001158863 us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-06-30 0001158863 us-gaap:FairValueInputsLevel1Member 2019-06-30 0001158863 us-gaap:CashEquivalentsMember us-gaap:FairValueInputsLevel2Member 2019-06-30 0001158863 us-gaap:FairValueInputsLevel2Member 2019-06-30 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001158863 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-06-30 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentDebtSecuritiesMember 2019-06-30 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2019-06-30 0001158863 us-gaap:CashEquivalentsMember us-gaap:FairValueInputsLevel1Member 2019-06-30 0001158863 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member 2019-06-30 0001158863 us-gaap:MunicipalBondsMember us-gaap:FairValueInputsLevel1Member 2019-06-30 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2019-06-30 0001158863 us-gaap:MunicipalBondsMember us-gaap:FairValueInputsLevel2Member 2019-06-30 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001158863 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentDebtSecuritiesMember 2019-06-30 0001158863 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2019-06-30 0001158863 us-gaap:FairValueInputsLevel1Member us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember 2019-06-30 0001158863 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2019-06-30 0001158863 us-gaap:TradeAccountsReceivableMember 2018-12-31 0001158863 wage:UnpaidAmountsForBenefitServicesMember 2019-06-30 0001158863 wage:UnpaidAmountsForBenefitServicesMember 2018-12-31 0001158863 us-gaap:TradeAccountsReceivableMember 2019-06-30 0001158863 us-gaap:FurnitureAndFixturesMember 2018-12-31 0001158863 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2018-12-31 0001158863 us-gaap:FurnitureAndFixturesMember 2019-06-30 0001158863 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2019-06-30 0001158863 us-gaap:ComputerEquipmentMember 2019-06-30 0001158863 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2018-12-31 0001158863 us-gaap:ComputerEquipmentMember 2018-12-31 0001158863 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2019-06-30 0001158863 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2018-04-01 2018-06-30 0001158863 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2018-01-01 2018-06-30 0001158863 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2019-01-01 2019-06-30 0001158863 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2019-04-01 2019-06-30 0001158863 us-gaap:LeaseAgreementsMember 2019-06-30 0001158863 wage:ClientContractsAndBrokerRelationshipsMember 2019-06-30 0001158863 us-gaap:NoncompeteAgreementsMember 2018-12-31 0001158863 us-gaap:TradeNamesMember 2019-06-30 0001158863 wage:ClientContractsAndBrokerRelationshipsMember 2018-12-31 0001158863 us-gaap:DevelopedTechnologyRightsMember 2019-06-30 0001158863 us-gaap:DevelopedTechnologyRightsMember 2018-12-31 0001158863 us-gaap:LeaseAgreementsMember 2018-12-31 0001158863 us-gaap:NoncompeteAgreementsMember 2019-06-30 0001158863 us-gaap:TradeNamesMember 2018-12-31 0001158863 us-gaap:RevolvingCreditFacilityMember 2017-04-04 0001158863 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-06-30 0001158863 us-gaap:RevolvingCreditFacilityMember 2019-06-30 0001158863 us-gaap:LetterOfCreditMember 2017-04-04 0001158863 2017-04-04 0001158863 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2018-12-31 0001158863 us-gaap:LetterOfCreditMember 2018-12-31 0001158863 us-gaap:LetterOfCreditMember 2019-06-30 0001158863 2018-08-07 2018-08-07 0001158863 srt:MaximumMember 2019-06-30 0001158863 wage:OPMClaimsDenialMember us-gaap:PositiveOutcomeOfLitigationMember 2017-12-22 0001158863 2018-06-22 2018-06-22 0001158863 2018-09-06 2018-09-06 0001158863 srt:MinimumMember 2019-06-30 0001158863 2019-03-11 0001158863 2019-03-11 2019-03-11 0001158863 2018-01-01 2018-12-31 0001158863 wage:PerformanceBasedRestrictedStockUnitsMember 2019-01-01 2019-06-30 0001158863 wage:ServicebasedRestrictedStockMember 2019-01-01 2019-06-30 0001158863 wage:ServicebasedRestrictedStockMember 2019-06-30 0001158863 wage:ServicebasedRestrictedStockMember 2018-12-31 0001158863 wage:PerformanceBasedRestrictedStockUnitsMember 2018-12-31 0001158863 wage:PerformanceBasedRestrictedStockUnitsMember 2019-06-30 0001158863 wage:PerformanceBasedRestrictedStockUnitsMember 2019-04-01 2019-06-30 0001158863 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-06-30 0001158863 srt:MaximumMember 2019-01-01 2019-06-30 0001158863 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-01-01 2019-06-30 0001158863 us-gaap:RestrictedStockUnitsRSUMember 2018-04-01 2018-06-30 0001158863 us-gaap:RestrictedStockUnitsRSUMember 2019-06-30 0001158863 us-gaap:RestrictedStockUnitsRSUMember 2019-04-01 2019-06-30 0001158863 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-06-30 0001158863 us-gaap:SellingAndMarketingExpenseMember 2018-04-01 2018-06-30 0001158863 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-06-30 0001158863 us-gaap:ResearchAndDevelopmentExpenseMember 2019-04-01 2019-06-30 0001158863 us-gaap:SellingAndMarketingExpenseMember 2019-01-01 2019-06-30 0001158863 us-gaap:SellingAndMarketingExpenseMember 2018-01-01 2018-06-30 0001158863 us-gaap:GeneralAndAdministrativeExpenseMember 2019-04-01 2019-06-30 0001158863 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-06-30 0001158863 us-gaap:ResearchAndDevelopmentExpenseMember 2018-04-01 2018-06-30 0001158863 us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001158863 us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001158863 us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001158863 us-gaap:GeneralAndAdministrativeExpenseMember 2018-01-01 2018-06-30 0001158863 us-gaap:SellingAndMarketingExpenseMember 2019-04-01 2019-06-30 0001158863 us-gaap:GeneralAndAdministrativeExpenseMember 2018-04-01 2018-06-30 0001158863 us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001158863 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-06-30 xbrli:shares wage:segment xbrli:pure iso4217:USD iso4217:USD xbrli:shares wage:extend_option wage:lawsuit utreg:sqft

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________________________________________________

FORM 10-Q

__________________________________________________________



(Mark One)
☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019



☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from____________ to ____________

Commission File Number: 001-35232

__________________________________________________________

WAGEWORKS, INC.

(Exact name of Registrant as specified in its charter)

__________________________________________________________



Delaware		94-3351864
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

໿

1100 Park Place , 4th Floor

San Mateo , California 94403

(Address of principal executive offices and Zip Code)

( 650 ) 577-5200

(Registrant’s telephone number, including area code)

________________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:



Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value per share	WAGE	The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (“Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No []

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No []

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



Large Accelerated Filer	[X]		Accelerated Filer	[ ]
Non-accelerated Filer	[ ]	(Do not check if a smaller reporting company)	Smaller Reporting Company	☐
			Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No [X]

As of August 2, 2019 , there were 40,371,122 shares of the registrant’s common stock outstanding .

WAGEWORKS, INC.

FORM 10-Q QUARTERLY REPORT

Table of Contents



		Page No.
	PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)	3

	Condensed Consolidated Balance Sheets as of June 30, 2019 and December 31, 2018	3

	Condensed Consolidated Statements of Income for the Three and Six Months Ended June 30, 2019 and 2018	4

	Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended June 30, 2019 and 2018	5

	Condensed Consolidated Statements of Stockholders’ Equity for the Three and Six Months Ended June 30, 2019 and 2018	6

	Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2019 and 2018	8

	Notes to Condensed Consolidated Financial Statements	9

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	32

Item 4.	Controls and Procedures	32

	PART II. OTHER INFORMATION

Item 1.	Legal Proceedings	34

Item 1A.	Risk Factors	34

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35

Item 4.	Mine Safety Disclosures	35

Item 5.	Other Information	35

Item 6.	Exhibits	37

	Signatures	38

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

WAGEWORKS, INC.

Condensed Consolidated Balance Sheets

(In thousands, except per share amounts)



	June 30, 2019			December 31, 2018
	(Unaudited)			Derived from Audited Financial Statements
Assets
Current assets:
Cash and cash equivalents	$	807,128		$	898,426
Restricted cash	—			333
Short-term investments	160,915			222,205
Receivables, net	89,632			101,297
Prepaid expenses and other current assets	28,756			23,662
Total current assets	1,086,431			1,245,923
Property and equipment, net	72,379			76,920
Operating lease right-of-use assets	22,679			—
Goodwill	297,409			297,409
Acquired intangible assets, net	117,391			130,095
Deferred tax assets, net	1,202			1,482
Other assets	31,878			33,324
Total assets	$	1,629,369		$	1,785,153
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued expenses	$	88,663		$	97,347
Customer obligations	674,879			762,100
Short-term operating lease liabilities	8,242			—
Other current liabilities	11,544			4,264
Total current liabilities	783,328			863,711
Long-term debt, net of issuance costs	144,906			244,693
Long-term operating lease liabilities	26,358			—
Other long-term liabilities	2,180			11,608
Total liabilities	956,772			1,120,012
Commitments and Contingencies (Note 10)
Stockholders’ Equity:
Common stock, par value $0.001 per share (1,000,000 shares authorized; 40,350 shares issued and 39,870 shares outstanding at June 30, 2019 and 40,333 shares issued and 39,853 shares outstanding at December 31, 2018)	41			41
Additional paid-in capital	583,288			582,521
Treasury stock at cost (480 shares at June 30, 2019 and December 31, 2018)	(22,309		)	(22,309		)
Accumulated other comprehensive income (loss)	81			(754		)
Retained earnings	111,496			105,642
Total stockholders’ equity	672,597			665,141
Total liabilities and stockholders’ equity	$	1,629,369		$	1,785,153

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

WAGEWORKS, INC.

Condensed Consolidated Statements of Income

(In thousands, except per share amounts)

(Unaudited )



	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018
Revenues:
Healthcare	$	65,172		$	68,104		$	137,146		$	143,361
COBRA	20,316			26,200			43,905			55,035
Commuter	19,560			18,847			38,900			37,725
Other	3,581			3,357			6,903			7,028
Total revenues	108,629			116,508			226,854			243,149
Operating expenses:
Cost of revenues (excluding amortization of internal use software)	36,660			36,143			75,918			81,386
Technology and development	15,600			13,392			31,940			26,425
Sales and marketing	18,269			18,521			36,600			36,859
General and administrative	24,672			18,898			52,581			44,147
Amortization	11,041			10,191			21,892			20,182
Employee termination and other charges	—			2,853			—			2,853
Total operating expenses	106,242			99,998			218,931			211,852
Income from operations	2,387			16,510			7,923			31,297
Interest and other income, net	2,883			1,455			5,532			2,721
Interest expense	(2,164		)	(2,420		)	(4,873		)	(4,602		)
Income before income taxes	3,106			15,545			8,582			29,416
Income tax provision	(1,309		)	(4,621		)	(2,728		)	(7,473		)
Net income	$	1,797		$	10,924		$	5,854		$	21,943
Net income per share:
Basic	$	0.05		$	0.27		$	0.15		$	0.55
Diluted	$	0.04		$	0.27		$	0.14		$	0.54
Shares used in computing net income per share:
Basic	39,861			39,853			39,857			39,838
Diluted	40,618			40,412			40,528			40,446

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

WAGEWORKS, INC.

Condensed Consolidated Statements of Comprehensive Income

(In thousands) (Unaudited )



	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019	2018
Net income	$	1,797	$	10,924	5,854	21,943
Net unrealized gain (loss) on short-term investments, net of tax	303		47		835	(684	)
Total comprehensive income	$	2,100	$	10,971	6,689	21,259

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

WAGEWORKS, INC.

Condensed Consolidated Statements of Stockholders’ Equity

(In thousands) (Unaudited)



	Three and Six Months Ended June 30, 2019
	Common stock			Additional paid-in capital			Treasury stock at cost			Accumulated other comprehensive income (loss)			Retained earnings		Total stockholders’ equity
	Shares	Amount		Additional paid-in capital			Treasury stock at cost			Accumulated other comprehensive income (loss)			Retained earnings		Total stockholders’ equity
Balance at December 31, 2018	39,853	$	41	$	582,521		$	(22,309	)	$	(754	)	$	105,642	$	665,141
Stock-based compensation expense	—	—		2,904			—			—			—		2,904
Capitalized stock-based compensation	—	—		53			—			—			—		53
Other comprehensive income, net of tax	—	—		—			—			532			—		532
Net income	—	—		—			—			—			4,057		4,057
Balance at March 31, 2019	39,853	41		585,478			(22,309		)	(222		)	109,699		672,687
Exercise of stock options	17	—		316			—			—			—		316
Stock-based compensation expense (reversal), net	—	—		(2,545		)	—			—			—		(2,545		)
Capitalized stock-based compensation	—	—		39			—			—			—		39
Other comprehensive income, net of tax	—	—		—			—			303			—		303
Net income	—	—		—			—			—			1,797		1,797
Balance at June 30, 2019	39,870	$	41	$	583,288		$	(22,309	)	$	81		$	111,496	$	672,597

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

WAGEWORKS, INC.

Condensed Consolidated Statements of Stockholders’ Equity

(In thousands) (Unaudited)



	Three and Six Months Ended June 30, 2018
	Common stock			Additional paid-in capital			Treasury stock at cost			Accumulated other comprehensive loss			Retained earnings		Total stockholders’ equity
	Shares	Amount		Additional paid-in capital			Treasury stock at cost			Accumulated other comprehensive loss			Retained earnings		Total stockholders’ equity
Balance at December 31, 2017	39,771	$	41	$	562,131		$	(22,309	)	$	(354	)	$	72,741	$	612,250
Exercise of stock options	54	—		1,395			—			—			—		1,395
Issuance of common stock under Employee Stock Purchase Plan	18	—		869			—			—			—		869
Issuance of restricted stock units, net of shares withheld for employee taxes	10	—		(281		)	—			—			—		(281		)
Stock-based compensation expense	—	—		7,293			—			—			—		7,293
Capitalized stock-based compensation	—	—		191			—			—			—		191
Other comprehensive loss, net of tax	—	—		—			—			(731		)	—		(731		)
ASC 606 cumulative-effect adjustment	—	—		—			—			—			6,955		6,955
Net income	—	—		—			—			—			11,019		11,019
Balance at March 31, 2018	39,853	41		571,598			(22,309		)	(1,085		)	90,715		638,960
Stock-based compensation expense	—	—		1,588			—			—			—		1,588
Capitalized stock-based compensation	—	—		68			—			—			—		68
Other comprehensive income, net of tax	—	—		—			—			47			—		47
Net income	—	—		—			—			—			10,924		10,924
Balance at June 30, 2018	39,853	$	41	$	573,254		$	(22,309	)	$	(1,038	)	$	101,639	$	651,587

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

WAGEWORKS, INC.

Condensed Consolidated Statements of Cash Flows

(In thousands) (Unaudited)



	Six Months Ended June 30,
	2019			2018
Cash flows from operating activities:
Net income	$	5,854		$	21,943
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	29,419			26,834
Amortization of debt issuance costs	363			242
Amortization of contract costs	1,536			1,576
Stock-based compensation expense	359			8,881
Provision for doubtful accounts	510			98
Other	172			(379		)
Changes in operating assets and liabilities:
Receivables	11,155			20,312
Prepaid expenses and other current assets	(5,094		)	6,964
Other assets	(90		)	(14,109		)
Accounts payable and accrued expenses	(11,025		)	(1,755		)
Customer obligations	(87,221		)	(57,879		)
Other liabilities	9,870			831
Net cash (used in) provided by operating activities	(44,192		)	13,559
Cash flows from investing activities:
Purchases of property and equipment	(9,694		)	(19,834		)
Purchases of short-term investments	(10,930		)	(122,823		)
Proceeds from sales of short-term investments	6,316			4,096
Proceeds from maturities of short-term investments	66,860			56,665
Purchases of intangible assets	(60		)	(209		)
Net cash provided by (used in) investing activities	52,492			(82,105		)
Cash flows from financing activities:
Proceeds from exercise of common stock options	316			1,396
Proceeds from issuance of common stock under Employee Stock Purchase Plan	—			869
Payments of debt modification costs	(150		)	(500		)
Payments of debt principal	(100,000		)	—
Payment of finance lease obligations	(97		)	(152		)
Taxes paid related to net share settlement of stock-based compensation arrangements	—			(218		)
Net cash (used in) provided by financing activities	(99,931		)	1,395
Net decrease in cash and cash equivalents, unrestricted and restricted	(91,631		)	(67,151		)
Cash and cash equivalents at beginning of period, unrestricted and restricted	898,759			779,677
Cash and cash equivalents at end of period, unrestricted and restricted	$	807,128		$	712,526

Supplemental cash flow disclosure:
Cash paid during the period for:
Interest	$	4,786		$	4,139
Income taxes	$	3,814		$	1,979
Noncash financing and investing activities:
Property and equipment, accrued but not paid	$	2,341		$	3,168
Property and equipment under finance lease	$	—		$	142

໿

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 1 Summary of Business and Significant Accounting Policies

Business

WageWorks, Inc., (together with its subsidiaries, “WageWorks” or the “Company”) was incorporated in the state of Delaware in 2000. The Company is a leader in administering Consumer-Directed Benefits (“CDBs”), which empower employees to lower their healthcare related expenditures while also providing corporate tax advantages for employers.

The Company operates as a single reportable segment on an entity level basis, and considers itself to operate under one operating and reporting segment with healthcare, transit and other employer sponsored programs representing a group of similar product lines. The Company believes that it engages in a single business activity and operates in a single economic environment.

Proposed Merger with HealthEquity, Inc.

On June 26, 2019, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with HealthEquity, Inc., a Delaware corporation (“HealthEquity”), and Pacific Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of HealthEquity (“Merger Sub”). The Merger Agreement provides that, subject to the terms and conditions set forth therein, Merger Sub will merge with and into WageWorks (the “Merger”), with WageWorks surviving the Merger and becoming a wholly owned subsidiary of HealthEquity.

Under the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of WageWorks common stock (other than shares (i) owned in treasury by WageWorks, (ii) owned by HealthEquity, Merger Sub or any other direct or indirect wholly owned subsidiary of HealthEquity, and (iii) held by WageWorks stockholders who perfect their appraisal rights with respect to the Merger) will be cancelled and automatically converted into the right to receive $51.35 in cash, without interest (the “Merger Consideration”).

Under the Merger Agreement, at the effective time of the Merger, (x) each outstanding WageWorks stock option (whether vested or unvested) will be cancelled and, if the exercise price per share of such stock option is less than $51.35 , will be exchanged for an amount of cash, without interest, equal to (1) the Merger Consideration less the applicable exercise price per share with respect to such stock option multiplied by (2) the number of shares covered by such stock option, (y) each outstanding award of WageWorks RSUs subject to only time-based vesting conditions (1) granted prior to June 26, 2019 will fully vest and be entitled to receive the Merger Consideration for each share covered by such award or (2) granted on or after June 26, 2019, will, as of the effective time of the Merger, be assumed by HealthEquity and converted automatically into an award of RSUs covering an adjusted (based on the ratio of the Merger Consideration to the volume weighted average price of a share of common stock of HealthEquity for the 20 trading days ending with the trading day immediately preceding the date of the closing of the Merger) number of shares of common stock of HealthEquity and will be subject to the same terms and conditions applicable to such RSUs immediately prior to the Effective Time, and (z) each outstanding award of WageWorks RSUs granted prior to June 26, 2019 and subject to performance-based vesting conditions (each, a “Performance Unit”) will (1) in the case of any Performance Unit for which the performance period is complete but for which the board of directors of WageWorks has not determined the achievement of the underlying performance goals, vest based on actual performance, (2) in the case of any Performance Unit for which the performance period is incomplete, vest based on target performance, and (3) in the case of any Performance Unit that does not vest in accordance with clause (1) or (2), be cancelled for no consideration. Each Performance Unit that vests according to the previous sentence will be cancelled in exchange for an amount of cash, without interest, equal to the Merger Consideration multiplied by the number of shares covered by such vested Performance Unit.

WageWorks has made customary representations, warranties and covenants in the Merger Agreement, including covenants not to, during the pendency of the Merger, solicit alternative transactions or, subject to certain exceptions, enter into discussions concerning, or provide confidential information in connection with, an alternative transaction. Each of HealthEquity and Merger Sub also has made customary representations, warranties and covenants in the Merger Agreement.

Consummation of the Merger is subject to the satisfaction or waiver of customary closing conditions, including adoption of the Merger Agreement by WageWorks’ stockholders. The early termination of the waiting period applicable to the Merger under

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976 was granted by the Federal Trade Commission on July 29, 2019. The transaction is not subject to any financing condition.

The Merger Agreement contains certain customary termination rights for HealthEquity and WageWorks, including a right to terminate the Merger Agreement if the Merger is not completed by December 26, 2019, unless otherwise extended pursuant to the terms of the Merger Agreement. The Merger Agreement further provides that, upon termination of the Merger Agreement under certain specified circumstances, WageWorks will be obligated to pay HealthEquity a termination fee of $69,656,872 .

Basis of Presentation

The unaudited interim condensed consolidated financial statements and the related notes have been prepared on the same basis as the audited consolidated financial statements and reflect all adjustments that, in the opinion of management, are necessary for a fair presentation of the results for the interim periods presented in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The results of the interim periods presented herein are not necessarily indicative of the results of future periods or annual results for the year ending December 31, 2019 .

These unaudited interim condensed consolidated financial statements and the related notes should be read in conjunction with the December 31, 2018 audited financial statements and related notes, together with management’s discussion and analysis of financial condition and results of operations, included in the Company’s Annual Report on Form 10-K. The December 31, 2018 consolidated balance sheet included in this interim Quarterly Report on Form 10-Q was derived from audited financial statements.

There have been no material changes to the Company’s critical accounting estimates during the three and six months ended June 30, 2019 . Other than the adoption of ASU 2016-02, “Leases (Topic 842)” , there have been no material changes to the Company's critical accounting policies during the three and six months ended June 30, 2019 from the items the Company disclosed in its Annual Report on Form 10-K for the year ended December 31, 2018 .

Reclassifications

Certain prior period amounts have been reclassified to conform to current period presentation, including the reclassification of deferred revenue from accounts payable and accrued expenses to other current liabilities in the condensed consolidated balance sheet as of December 31, 2018 and the statement of cash flows for the six months ended June 30, 2018 . There was no impact on the condensed consolidated statements of income for the three and six months ended June 30, 2018 .

Principles of Consolidation

The unaudited condensed consolidated financial statements include the accounts of WageWorks, Inc. and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

In preparing the condensed consolidated financial statements and related disclosures in conformity with GAAP, and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), the Company must make estimates and judgments that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. Estimates are used for, but not limited to revenue recognition, allowances for doubtful accounts, useful lives for depreciation and amortization, loss contingencies, income taxes, the assumptions used for stock-based compensation including attainment of performance-based awards, the assumptions used for software and web site development cost classification, and recoverability and impairments of goodwill and long-lived assets and average customer life. Actual results may be materially different from those estimates. In making its estimates, the Company considers the current economic and legislative environment.

Leases

The Company leases office space under noncancelable operating leases. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the implicit rate is not readily determinable in most of the Company’s lease agreements, the Company uses its estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

is recognized on a straight-line basis over the lease term. In addition, the Company made an accounting policy election to keep leases with an initial term of 12 months or less off of the balance sheet.

The Company determines if an arrangement is a lease or contains a lease at inception. The Company applied the short-term lease measurement and recognition exemption in which right-of-use (“ROU”) assets and lease obligations are not recognized for short-term leases. The Company does not have lease agreements with residual value guarantees, sales leaseback terms or material restrictive covenants. The Company has one sublease for which the sublease income was recorded as a reduction to operating lease expense for the three and six months ended June 30, 2019 and 2018 .

The Company has lease agreements that contain both lease and non-lease components. For real estate leases, the Company accounts for lease components together with non-lease components (e.g., common-area maintenance). Amounts recognized as ROU assets related to finance leases are included in property and equipment, net in the accompanying condensed consolidated balance sheets, while related lease liabilities are included in other current liabilities and other long-term liabilities.

Recently Adopted Accounting Guidance

In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-02, Leases (Topic 842). In January 2019 the FASB issued ASU 2019-01 which amended the transition disclosure requirements for Topic 842. Topic 842 requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating lease.

The Company adopted Topic 842 prospectively during the first quarter of 2019. As part of its adoption, the Company elected a package of practical expedients for leases that commenced prior to January 1, 2019 and did not reassess: (i) whether any expired or existing contracts are or contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs capitalization for any existing leases. The Company recognizes those lease payments in the condensed consolidated statements of income on a straight-line basis over the lease term.

The adoption of Topic 842 resulted in the Company recording $25.5 million of right-of-use lease assets and $38.4 million of lease liabilities as of January 1, 2019. The new standard did not have a significant impact on the condensed consolidated statements of income. See Note 10 , Commitments and Contingencies for additional information.

In February 2018, the FASB issued ASU No. 2018-02, “Income Statement - Reporting Comprehensive Income (Topic 220) - Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income” (ASU 2018-02). This standard allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act and requires certain disclosures about stranded tax effects. The Company adopted ASU 2018-02 on January 1, 2019 and applied it in the period of adoption. The Company did not elect to reclassify any tax effects of the Tax Cuts and Jobs Act on items within accumulated other comprehensive income to retained earnings. The adoption of this standard did not have an effect on the Company’s condensed consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-15, “Intangibles, Goodwill and Other (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract” (ASU 2018-15). ASU 2018-15 requires implementation costs incurred by customers in cloud computing arrangements to be deferred, if those same costs would be capitalized by a customer in a software licensing arrangement under the internal-use software guidance in ASC 350-40. ASU 2018-15 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019, with early adoption permitted. The Company elected to early adopt the new standard as of March 31, 2019. The adoption of this standard did not have a material effect on the Company’s condensed consolidated financial statements.

Recently Issued Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, “ Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (ASU 2016-13) , which amends the FASB’s guidance on the impairment of financial instruments. In April 2019 the FASB issued ASU No. 2019-04, “ Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments” , which contains a compilation of guidance to assist

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

practitioners with the implementation and application of ASU 2016-13, among others. ASU 2016-13 adds to GAAP an impairment model (known as the “current expected credit loss model”) that is based on expected losses rather than incurred losses. ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the timing and impact of adoption on its consolidated financial statements.

In January 2017, the FASB issued ASU No. 2017-04, “ Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” The amendments eliminate Step 2 from the goodwill impairment test. The annual, or interim, goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In addition, income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit should be considered when measuring the goodwill impairment loss, if applicable. The amendments also eliminate the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The new standard is effective for fiscal years beginning after December 15, 2019, with early adoption permitted. The Company is currently evaluating the timing and impact of adoption on the Company’s consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, “ Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement” (ASU 2018-13) . The primary focus of ASU 2018-13 is to improve the effectiveness of the disclosure requirements for fair value measurements. The changes affect all companies that are required to include fair value measurement disclosures. In general, the amendments in this standard are effective for all entities for fiscal years and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted. The Company is currently evaluating the timing and impact of adoption on its consolidated financial statements.

In November 2018, the FASB issued ASU No. 2018-19, “ Codification Improvements to Topic 326, Financial Instruments-Credit Losses.” ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the leases standard. In general, the amendments in this standard are effective for public business entities that meet the definition of a SEC filer for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company is currently evaluating the timing and impact of adoption on its consolidated financial statements.

Note 2 Net Income per Share

The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data): ໿



	Three months ended June 30,				Six months ended June 30,
	2019		2018		2019		2018
Numerator: Net income	$	1,797	$	10,924	$	5,854	$	21,943

Denominator:
Basic weighted-average shares	39,861		39,853		39,857		39,838
Effect of potentially dilutive shares:
Weighted-average dilutive stock options, restricted stock and performance restricted stock units, and employee stock purchase plan shares	757		559		671		608
Diluted weighted-average shares	40,618		40,412		40,528		40,446

Net income per share:
Basic	$	0.05	$	0.27	$	0.15	$	0.55
Diluted	$	0.04	$	0.27	$	0.14	$	0.54

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

For the three months ended June 30, 2019 and 2018 , potential shares from stock options and restricted stock units totaling 1.9 million and 1.8 million , respectively, are not included in the computation of diluted earnings per share because their inclusion would have been anti-dilutive. For the six months ended June 30, 2019 and 2018 , potential shares from stock options and restricted stock units totaling 1.9 million and 1.6 million , respectively, are not included in the computation of diluted earnings per share because their inclusion would have been anti-dilutive.

Note 3 Revenue

The Company generally invoices its customers on a monthly basis with a term of net 30-60 days. The Company applies the practical expedient provided by ASC 606 and does not evaluate contracts of one year or less for the existence of a significant financing component. The Company’s policy is to exclude sales and other indirect taxes when measuring the transaction price of its subscription agreements.

Disaggregation of Revenues

The Company’s primary categories of revenue are Healthcare, Commuter, COBRA and Other revenue and are disclosed in the condensed consolidated statements of income. The following table provides information about disaggregated revenue from contracts with customers by the nature of the products and services (in thousands):



	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
Benefit administration services and COBRA	$	87,763	$	96,258	$	183,723	$	200,699
Interchange	13,245		13,555		28,684		29,300
Other	7,621		6,695		14,447		13,150
Total	$	108,629	$	116,508	$	226,854	$	243,149

Contract Balances

The Company generally does not recognize revenue in advance of invoicing its customers, however, it records a receivable when revenue is recognized prior to invoicing and it has an unconditional right to payment. Alternatively, when payment precedes the related services, the Company records a contract liability, or deferred revenue, until its performance obligations are satisfied. The Company’s deferred revenue as of June 30, 2019 and December 31, 2018 was $12.6 million and $3.9 million , respectively. The balances relate to up-front fees, cash received in advance for a certain interchange revenue arrangement, and other commuter deferred revenue. The Company expects to satisfy its remaining obligations for these arrangements.

Contract Costs

Contract costs relate to incremental costs of obtaining a contract with a customer. Contract costs, which primarily consist of deferred sales commissions, were $9.0 million and $8.8 million as of June 30, 2019 and December 31, 2018 , respectively and are included in other assets on the condensed consolidated balance sheets. Amortization expense for the deferred costs was $0.8 million and $0.7 million for the three months ended June 30, 2019 and 2018 , respectively, and $1.5 million and $1.6 million for the six months ended June 30, 2019 and 2018 , respectively. There was no impairment loss in relation to the costs capitalized for the periods presented. Deferred contract costs are amortized on a straight-line basis over the period of benefit, which is consistent with the pattern of transfer of the good or service to which the asset relates.

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

Performance Obligations

During the three and six months ended June 30, 2019 , the Company recognized the following revenues (in thousands):



	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
Revenues recognized in the period for:
Performance obligations satisfied from amounts included in contract liabilities at the beginning of the period	$	143	$	143	$	286	$	286
Performance obligations satisfied from new activities in the period - contract revenues	108,486		116,365		226,568		242,863
Total revenues	$	108,629	$	116,508	$	226,854	$	243,149

The following table includes estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period (in thousands). The Company applies the practical expedient to not disclose information about contracts with original expected durations of one year or less, amounts of variable consideration attributable to the variable consideration allocation exception, or contract renewals that are unexercised as of June 30, 2019 .



	June 30, 2019
2019 (remainder of year)	$	286
2020	571
2021	571
2022 and thereafter	1,143
Total	$	2,571

Note 4 Investments and Fair Value Measurements

The following tables summarize the Company’s investments in marketable securities and fair value measurements by investment category reported as cash equivalents and short-term investments as of June 30, 2019 and December 31, 2018 (in thousands):



June 30, 2019	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		Level 1		Level 2
Cash equivalents:
Money market funds	$	41,570	$	—	$	—		$	41,570	$	41,570	$	—
Commercial paper	32,848		1		(5		)	32,844		—		32,844
Municipal bonds	10,382		—		—			10,382		—		10,382
Total cash equivalents	84,800		1		(5		)	84,796		41,570		43,226

Short-Term Investments:
U.S. government securities	15,564		1		(10		)	15,555		15,555		—
U.S. government agency securities	10,842		4		(9		)	10,837		—		10,837
Municipal bonds	2,295		2		—			2,297		—		2,297
Corporate debt securities	100,364		199		(49		)	100,514		—		100,514
Commercial paper	5,994		—		—			5,994		—		5,994
Asset-backed securities	25,732		14		(28		)	25,718		—		25,718
Total short-term investments	160,791		220		(96		)	160,915		15,555		145,360
Total cash equivalents and short-term investments	$	245,591	$	221	$	(101	)	$	245,711	$	57,125	$	188,586

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)



December 31, 2018	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		Level 1		Level 2
Cash equivalents:
Money market funds	$	41,027	$	—	$	—		$	41,027	$	41,027	$	—
Commercial paper	10,436		1		—			10,437		—		10,437
Municipal bonds	7,781		—		—			7,781		—		7,781
Total cash equivalents	59,244		1		—			59,245		41,027		18,218

Short-Term Investments:
U.S. government securities	22,534		—		(94		)	22,440		22,440		—
U.S. government agency securities	14,346		—		(56		)	14,290		—		14,290
Municipal bonds	3,548		—		(4		)	3,544		—		3,544
Foreign government securities	2,504		—		(6		)	2,498		—		2,498
Corporate debt securities	134,003		37		(685		)	133,355		—		133,355
Commercial paper	12,954		—		(4		)	12,950		—		12,950
Certificates of deposit	1,258		—		—			1,258		—		1,258
Asset-backed securities	32,054		—		(184		)	31,870		—		31,870
Total short-term investments	223,201		37		(1,033		)	222,205		22,440		199,765
Total cash equivalents and short-term investments	$	282,445	$	38	$	(1,033	)	$	281,450	$	63,467	$	217,983

As of June 30, 2019 , the Company’s unrealized losses on investments were deemed temporary in nature.

The following tables summarize the gross unrealized losses and fair values of investments in an unrealized loss position as of June 30, 2019 and December 31, 2018 , aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position (in thousands):



	Less than 12 months					12 months or greater					Total
June 30, 2019	Fair Value		Gross Unrealized Loss			Fair Value		Gross Unrealized Loss			Fair Value		Gross Unrealized Loss
Cash equivalents:
Commercial paper	$	29,851	$	(5	)	$	—	$	—		$	29,851	$	(5	)
Total cash equivalents in unrealized loss position	29,851		(5		)	—		—			29,851		(5		)

Short-Term Investments:
U.S. government securities	—		—			13,035		(10		)	13,035		(10		)
U.S. government agency securities	—		—			8,822		(9		)	8,822		(9		)
Corporate debt securities	6,389		(4		)	55,447		(45		)	61,836		(49		)
Commercial paper	5,993		—			—		—			5,993		—
Asset-backed securities	3,550		(3		)	12,850		(25		)	16,400		(28		)
Total short-term investments in unrealized loss position	15,932		(7		)	90,154		(89		)	106,086		(96		)
Total cash equivalents and short-term investments in unrealized loss position	$	45,783	$	(12	)	$	90,154	$	(89	)	$	135,937	$	(101	)

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)



	Less than 12 months
December 31, 2018	Fair Value		Gross Unrealized Loss
Short-Term Investments:
U.S. government securities	$	22,440	$	(94	)
U.S. government agency securities	14,290		(56		)
Municipal bonds	3,544		(4		)
Foreign government securities	2,498		(6		)
Corporate debt securities	125,192		(685		)
Commercial paper	12,950		(4		)
Asset-backed securities	31,870		(184		)
Total short-term investments in unrealized loss position	$	212,784	$	(1,033	)

Realized gains and losses on marketable securities are included in other income (expense), net on the Company’s condensed consolidated statements of income. Gross realized losses on marketable securities for the three and six months ended June 30, 2019 and 2018 were not significant.

The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. There were no transfers between Level 1 and Level 2 fair value categories during the periods presented.

The following tables summarize the estimated amortized cost and fair value of the Company’s marketable securities by the contractual maturity date as of June 30, 2019 and December 31, 2018 (in thousands):



June 30, 2019	Amortized Cost		Fair Value
Due less than one year	$	221,054	$	221,026
Due in one to five years	24,537		24,685
Total	$	245,591	$	245,711



December 31, 2018	Amortized Cost		Fair Value
Due less than one year	$	219,057	$	218,394
Due in one to five years	63,388		63,056
Total	$	282,445	$	281,450

Note 5 Receivables

Receivables at June 30, 2019 and December 31, 2018 were comprised of the following (in thousands):



	June 30, 2019			December 31, 2018
Trade receivables	$	49,324		$	52,525
Unpaid amounts for benefit services	44,426			52,380
Receivables, gross	93,750			104,905
Less: allowance for doubtful accounts	(4,118		)	(3,608		)
Receivables, net	$	89,632		$	101,297

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

Note 6 Property and Equipment

Property and equipment at June 30, 2019 and December 31, 2018 were comprised of the following (in thousands):



	June 30, 2019			December 31, 2018
Computers and equipment	$	29,406		$	27,519
Software and software development costs	153,063			144,260
Furniture and fixtures	8,121			8,123
Leasehold improvements	28,951			28,883
Property and equipment, gross	219,541			208,785
Less: accumulated depreciation and amortization	(147,162		)	(131,865		)
Property and equipment, net	$	72,379		$	76,920

As of both June 30, 2019 and December 31, 2018 , total right-of-use assets related to finance leases were $1.2 million , and were classified as computers and equipment. Accumulated depreciation for assets under finance leases was $0.9 million and $0.8 million at June 30, 2019 and December 31, 2018 , respectively.

The Company capitalized software development costs of $4.5 million and $5.9 million for the three months ended June 30, 2019 and 2018 , respectively; and $8.9 million and $11.6 million for the six months ended June 30, 2019 and 2018 , respectively. Amortization expense related to capitalized software development costs was $4.6 million and $3.8 million for the three months ended June 30, 2019 and 2018 , respectively; and $9.1 million and $7.4 million for the six months ended June 30, 2019 and 2018 , respectively. These costs are included in amortization expense in the condensed consolidated statements of income. At June 30, 2019 , the unamortized software development costs included in property and equipment in the condensed consolidated balance sheets were $40.2 million .

Total depreciation expense plus amortization of capitalized software development costs for the three months ended June 30, 2019 and 2018 was $8.5 million and $7.3 million , respectively. Total depreciation expense plus amortization of capitalized software development costs for the six months ended June 30, 2019 and 2018 was $16.7 million and $14.1 million , respectively.

Note 7 Goodwill and Intangible Assets

Goodwill

There was no change in the carrying amount of goodwill for the three and six months ended June 30, 2019 .

Intangible Assets

Acquired intangible assets at June 30, 2019 and December 31, 2018 were comprised of the following (in thousands):



	June 30, 2019							December 31, 2018
	Gross carrying amount		Accumulated amortization			Net		Gross carrying amount		Accumulated amortization			Net
Amortizable intangible assets:
Client/broker contracts and relationships	$	237,490	$	(120,983	)	$	116,507	$	237,430	$	(108,834	)	$	128,596
Trade names	3,880		(3,635		)	245		3,880		(3,587		)	293
Technology	14,646		(14,490		)	156		14,646		(14,009		)	637
Noncompete agreements	2,232		(2,120		)	112		2,232		(2,084		)	148
Favorable lease agreements	1,134		(763		)	371		1,134		(713		)	421
Total	$	259,382	$	(141,991	)	$	117,391	$	259,322	$	(129,227	)	$	130,095

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

Amortization of intangible assets for the three months ended June 30, 2019 and 2018 was $6.4 million and $6.3 million , respectively. For the six months ended June 30, 2019 and 2018 , amortization of intangible assets was $12.8 million and $12.7 million , respectively.

The estimated amortization expense in future periods at June 30, 2019 is as follows (in thousands):

໿



	As of June 30, 2019
Remainder of 2019	$	12,181
2020	22,758
2021	19,953
2022	17,518
2023	14,728
Thereafter	30,253
Total	$	117,391

Note 8 Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses at June 30, 2019 and December 31, 2018 were comprised of the following (in thousands):



	June 30, 2019		December 31, 2018
Accounts payable and accrued liabilities	$	28,026	$	32,771
Payable to benefit providers and transit agencies	32,220		30,148
Accrued compensation and related benefits	24,180		28,594
Other accrued expenses	4,237		5,834
Accounts payable and accrued expenses	$	88,663	$	97,347

Note 9 Long-term debt

As of June 30, 2019 and December 31, 2018 , long-term debt consisted of the following (in thousands):



	June 30, 2019			December 31, 2018
Revolving credit facility used	$	149,830		$	249,830
Less: Outstanding letters of credit	(2,830		)	(2,830		)
Outstanding revolving credit facility	147,000			247,000
Unamortized loan issuance costs	(2,094		)	(2,307		)
Long-term debt, net of issuance costs	$	144,906		$	244,693

On April 4, 2017, the Company entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) with MUFG Union Bank, N.A., as administrative agent (“Agent”). The Credit Agreement amends and restates the Company’s existing Amended and Restated Credit Agreement, and increased the Company’s borrowing capacity under the revolving credit facility to $400.0 million , with a $15.0 million letter of credit sub-facility. The Credit Agreement contains an increase option permitting the Company, subject to certain conditions and requirements, to arrange with existing lenders and/or new lenders to provide up to an aggregate of $100.0 million in additional commitments. The principal, together with all accrued and unpaid interest, is due and payable on April 4, 2022. Loan proceeds may be used for general corporate purposes, including acquisitions permitted under the Credit Agreement. The Company may prepay loans under the Credit Agreement in whole or in part at any

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

time without premium or penalty. The fees incurred in connection with this Credit Agreement are classified as a direct deduction from long-term debt in the condensed consolidated balance sheets. The Second Amended Credit Agreement contains financial and non-financial covenants including debt ratio and interest coverage ratio requirements. The Company is currently in compliance with all the covenants under the credit facility.

In the first quarter of 2019, the Company entered into a Third Reporting Extension Agreement and paid the Agent $0.1 million to extend the delivery date of the 2018 Annual Report on Form 10-K to May 10, 2019. In the second quarter of 2019, the Company entered into a Fourth Reporting Extension Agreement and paid the Agent $0.1 million to extend the delivery date of the 2018 Annual Report on Form 10-K to May 31, 2019. The fees incurred were added to loan financing fees to be amortized to interest expense over the remaining life of the loan. The 2018 Annual Report on Form 10-K was filed on May 29, 2019.

As of June 30, 2019 , the Company had $147.0 million outstanding under the revolving credit facility and $250.2 million unused revolving credit facility still available to borrow under the Credit Agreement. As of June 30, 2019 , the interest rate applicable to the revolving credit facility was 3.90% per annum. See Note 10 for further information regarding letters of credit.

Note 10 Commitments and Contingencies

Operating Leases

The Company leases office space under noncancelable operating leases and leases various office equipment under finance lease arrangements. The Company’s leases have remaining lease terms of approximately 1 to 9 years , which may include the option to extend the lease when it is reasonably certain the Company will exercise that option. The exercise of lease renewal options is at the Company’s sole discretion. The components of operating lease expense were as follows (in thousands):



	Three Months Ended June 30, 2019			Six Months Ended June 30, 2019
Operating lease cost	$	1,806		$	3,620
Sublease income	(469		)	(938		)
Net lease cost	$	1,337		$	2,682

Rent expense under operating lease agreements was $1.9 million and $3.9 million for the three and six months ended June 30, 2018 , respectively.

Amortization and interest expense related to finance leases were not material during the three and six months ended June 30, 2019 .

As of June 30, 2019 , the weighted-average remaining lease term and discount rate for the Company’s operating leases are 4.9 and 4.6% , respectively.

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

As of June 30, 2019 , maturities of lease liabilities by fiscal year for the Company’s operating leases, excluding the future contractual sublease income of $7.3 million , were as follows (in thousands):



Years Ending December 31,	Operating Leases
2019 (remainder of year)	$	4,819
2020	9,700
2021	9,696
2022	6,536
2023	2,308
Thereafter	5,663
Total minimum lease payments	38,722
Less: imputed interest	(4,122		)
Present value of net minimum lease payments	34,600
Less: current portion	8,242
Long-term operating lease liabilities	$	26,358

Prior to the adoption of the new leases standard, future minimum lease payments under non-cancelable operating leases, excluding the contractual sublease income of $8.3 million which is expected to be received through February 2023, were as follows as of December 31, 2018 (in thousands):



Years Ending December 31,	Operating Leases
2019	$	9,479
2020	9,685
2021	9,661
2022	6,536
2023	2,308
Thereafter	5,663
Total future minimum lease payments	$	43,332

Operating cash outflows related to operating leases were $2.3 million and $4.7 million for the three and six months ended June 30, 2019 .

During the second quarter of 2019, the Company entered into a lease agreement with a period of approximately 10 years to occupy 150,000 square feet of new office space in Mesa, AZ. The base rent obligation of $63.1 million is expected to commence in the third quarter of 2020, and therefore is not included in the table above. In addition to the base rent payments, the Company will be obligated to pay certain customary amounts for its share of operating expenses and tax obligation. The Company has the option to extend the term of the lease for two additional periods of five years . Contractual obligations related to this lease are shown in the table below (in thousands):



	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years
Future lease obligation (Mesa)	$	63,094	$	—	$	5,803	$	11,944	$	45,347

Legal Matters

The Company is pursuing affirmative claims against the Office of Personnel Management (OPM) to obtain payment for services provided by the Company between March 1, 2016 and August 31, 2016 pursuant to its contract with OPM for the Government’s Federal Flexible Account Program (“FSAFEDS”). The Company initially issued its invoice for these services in February 2017. On December 22, 2017, the Company received the Contracting Officer’s “final decision” refusing payment of the invoiced amount and otherwise denying the Company’s Certified Claim. As a result of this decision, and a related Certified Claim

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

that OPM subsequently denied, on February 8, 2018, the Company filed an appeal to the Civilian Board of Contract Appeals (“CBCA”) against OPM for services provided by the Company between March 1, 2016 and August 31, 2016. On August 3, 2018, the Company also filed an appeal to the CBCA of OPM’s June 21, 2018 denial of a Request for Equitable Adjustment for extra work associated with a contract modification imposing new security and other requirements not part of the original scope of FSAFED’s contract work. In connection with the Company’s claims against OPM, OPM has also claimed that an erroneous statement in a certificate signed by a former executive officer constituted a violation of the False Claims Act and moved to dismiss part of the Company’s claim against OPM as a result. In March 2019, the Company filed a Motion for Summary Judgment with CBCA on the December 22nd denial by the OPM. OPM has moved to defer consideration of the Motion for Summary Judgment to permit it further discovery. That Motion has been granted, but the case is on hold pending a ruling by the CBCA on the scope of the further discovery permitted in connection with the Company’s underlying Motion for Summary Judgment. In order to accelerate resolution of all matters before the CBCA, the Company’s appeal of the June 21st denial by the OPM was withdrawn on April 9, 2019. The remaining claim related to the OPM’s December 22nd denial, valued at approximately $6.2 million , could be decided by a decision on the pending Motion for Summary Judgment, or go to trial if the Motion is denied. As with all legal proceedings, no assurance can be provided as to the outcome of these matters or if the Company will be successful in recovering the full claimed amount.

On March 9, 2018, a putative class action was filed in the United States District Court for the Northern District of California (the “Securities Class Action”). On May 16, 2019, a consolidated amended complaint was filed by the lead plaintiffs asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, against the Company, its former Chief Executive Officer and its former Chief Financial Officer on behalf of purchasers of WageWorks common stock between May 6, 2016 and March 1, 2018. The complaint also alleges claims under the Securities Act of 1933, as amended, arising from the Company’s June 19, 2017 common stock offering against those same defendants, as well as the members of its Board of Directors at the time of that offering and the underwriters of the offering.

On June 22, 2018 and September 6, 2018, two derivative lawsuits were filed against certain of our officers and directors and the Company (as nominal defendant) in the Superior Court of the State of California, County of San Mateo. The actions were consolidated. On July 23, 2018, a similar derivative lawsuit was filed against certain of our officers and directors and the Company (as nominal defendant) in the United States District Court for the Northern District of California (together, the “Derivative Suits”). The Derivative Suits purport to allege claims related to breaches of fiduciary duties, waste of corporate assets, and unjust enrichment. In addition, the complaint in District Court includes a claim for abuse of control, and the complaint in Superior Court includes a claim to require the Company to hold an annual shareholder meeting. The allegations in the Derivative Suits relate to substantially the same facts as those underlying the Securities Class Action described above. The plaintiffs seek unspecified damages and fees and costs. In addition, the complaint in the Superior Court seeks for us to provide past operational reports and financial statements, to publish timely and accurate operational reports and financial statements going forward, to hold an annual shareholder meeting, and to take steps to improve its corporate governance and internal procedures.

Plaintiffs in the Superior Court action filed a Consolidated Complaint on May 2, 2019. As stipulated by the parties, and approved by the District Court, the District Court action is stayed. The parties in the District Court action are to notify the District Court within 15 days of (1) the dismissal of the Securities Class Action, (2) the denial of defendants’ motion(s) to dismiss, or (3) a party giving notice that they no longer consent to the voluntary stay.

The Company voluntarily contacted the San Francisco office of the SEC Division of Enforcement regarding the restatement and independent investigation. The Company is providing information and documents to the SEC and will continue to cooperate with the SEC’s investigation into these matters. The U.S. Attorney’s Office for the Northern District of California also opened an investigation. The Company has provided documents and information to the U.S. Attorney’s Office and will continue to cooperate with any inquiries by the U.S. Attorney’s Office regarding the matter.

Beginning on July 30, 2019, putative class action suits were filed in the United States District Court Courts for the Southern District of New York, the District of Delaware, and the Northern District of California asserting claims under Sections 14(a) and 20(a) of the Securities Exchange Act of 1934, as amended, against the Company and the members of its Board of Directors. The complaints generally allege disclosure violations in the proxy statement issued by the Company in connection with the stockholder vote on the proposed merger with HealthEquity.

The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on currently available information, the Company does not believe that any additional liabilities relating to other unresolved matters are probable or that the amount of any resulting loss is estimable. In

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

addition, in accordance with the relevant authoritative guidance, for matters which the likelihood of material loss is at least reasonably possible, the Company provides disclosure of the possible loss or range of loss. If a reasonable estimate cannot be made, the Company will provide disclosure to that effect. However, litigation is subject to inherent uncertainties and the Company’s view of these matters may change in the future. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on the Company’s financial position, results of operations or cash flows for the period in which the unfavorable outcome occurs, and potentially in future periods.

The Company is involved in various other litigation, governmental proceedings and claims, not described above, that arise in the normal course of business. For example, on occasion a lawsuit will be filed against a customer of our COBRA business alleging that the customer’s COBRA election notice, which is typically drafted and sent out by the Company on behalf of the customer, did not fully comply with the law. Because the Company is not a proper party to such lawsuits, the Company’s involvement is typically brought on via a third-party subpoena and/or the customer defendant making an indemnification demand against the Company based on their services contract. We have and will continue to vigorously defend the Company’s interests in such lawsuits. While it is not possible to determine the ultimate outcome or the duration of such litigation, including any other litigation or any of the above described governmental proceedings or claims, the Company believes, based on current knowledge and the advice of counsel, that such litigation, proceedings and claims will not have a material impact on the Company’s financial position or results of operations.

Note 11 Stockholders’ Equity

Share Repurchase Program

On March 11, 2019, the Company’s Board of Directors authorized a $150 million stock repurchase program for 3 years which commenced on March 13, 2019 and expires on March 12, 2022 . Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase programs, or by any combination of such methods. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company’s stock price, corporate and regulatory requirements, restrictions under its debt obligations and other market and economic conditions. No shares of common stock have been repurchased under this program to date.

Note 12 Employee Benefit Plans

Stock-based compensation

Stock-based compensation is classified in the condensed consolidated statements of income in the same expense line items as cash compensation. Amounts recorded as expense in the condensed consolidated statements of income were as follows (in thousands):



	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018
Cost of revenues	$	414		$	660		$	939		$	2,327
Technology and development	270			586			785			1,161
Sales and marketing	344			772			975			1,750
General and administrative	(3,573		)	(430		)	(2,340		)	3,643
Total	$	(2,545	)	$	1,588		$	359		$	8,881

(a) Employee Stock Option Plan

In May 2010, the Company adopted the 2010 Equity Incentive Plan (“2010 Plan”). Under the 2010 Plan, the Company can grant share-based awards to all employees, including executive officers, outside consultants and non-employee directors. Options under the 2010 Plan generally have a term of 10 years and vest over 4 years with 25% vesting after one year of service and monthly vesting over the remaining period. As of June 30, 2019 , the 2010 Plan has a total of 5.4 million common stock shares available for issuance.

There were no stock options granted during the three and six months ended June 30, 2019 and 2018 as the Company did not file its Form S-8 until June 27, 2019.

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

Stock option activity for the six months ended June 30, 2019 was as follows (shares in thousands):



	Shares		Weighted-average exercise price		Remaining contractual term (in years)	Aggregate intrinsic value (in thousands)
Outstanding at December 31, 2018	2,219		$	46.50	5.11	$	4,321
Granted	—		—
Exercised	(17	)	18.58
Forfeited and cancelled	(43	)	$	26.21
Outstanding as of June 30, 2019	2,159		$	47.12	4.02	$	19,877
Vested and expected to vest at June 30, 2019	2,140		$	46.98	3.99	$	19,858
Exercisable at June 30, 2019	1,933		$	45.31	3.63	$	19,602

As of June 30, 2019 , there was $4.8 million of total unrecognized stock-based compensation expense associated with stock options which will be recognized over a weighted-average period of approximately 1 year . Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures.

(b) Restricted Stock Units

The Company grants restricted stock units (“RSU”) to certain employees, officers, and directors under the 2010 Plan. Restricted stock units vest upon performance-based or service-based criteria.

During the three and six months ended June 30, 2019 , the Company granted zero performance-based restricted stock units as the Company did not file its Form S-8 until June 27, 2019. The Company did not grant performance-based restricted stock units in 2018. Performance-based restricted stock units are typically granted such that they vest upon the achievement of certain revenue growth rates and other financial metrics during a specified performance period for which participants have the ability to receive up to 200% of the target number of shares originally granted, depending on terms of the grant agreement.

Stock-based compensation expense related to restricted stock units was $(3.7) million and $(1.1) million for the three months ended June 30, 2019 and 2018 , respectively; and was $ (2.2) million and $3.0 million for the six months ended June 30, 2019 and 2018 , respectively. Total unrecorded stock-based compensation expense at June 30, 2019 associated with restricted stock units was estimated at $42.0 million , which is expected to be recognized over a weighted-average period of approximately 3 years . In the second quarter of 2019, the Company reversed previously recognized expenses of $5.2 million related to performance-based RSUs because management determined that it is improbable that the performance requirements for such RSUs will be met based on the Company's operating results for the year-to-date period ended June 30, 2019 .

The following table summarizes information about restricted stock units issued to officers, directors and employees under the 2010 Plan (shares in thousands):



					Weighted-average grant date fair value
	Service- based RSUs		Performance- based RSUs		Service- based RSUs		Performance- based RSUs
Unvested at December 31, 2018	164		200		$	61.79	$	59.76
Granted	736		—		$	50.92	$	—
Vested	(35	)	(32	)	$	56.99	$	7.28
Forfeited and cancelled	(5	)	—		$	61.61	$	—
Unvested at June 30, 2019	860		168		$	52.68	$	72.30

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

Note 13 Income Taxes

The Company reports income taxes using an asset and liability approach, under which deferred income taxes are provided based upon enacted tax laws and rates applicable to periods in which the taxes become payable. The Company is subject to income taxes in the U.S. federal and various state jurisdictions. Presently, there are no income tax examinations on-going in the jurisdictions where the Company operates.

The Company’s effective tax rate was 42.1% and 29.7% for the three months ended June 30, 2019 and 2018 , respectively; and was 31.8% and 25.4% for the six months ended June 30, 2019 and 2018 , respectively. The increase in the rate of 12.4% and 6.4% for the three and six months ended June 30, 2019 respectively relates to the discrete impact recognition of an increase in unrecognized tax benefit to the income tax provision. The income tax provision for the three months ended June 30, 2019 and 2018 was $1.3 million and $4.6 million , respectively; and was $2.7 million and $7.5 million for the six months ended June 30, 2019 and 2018 , respectively.

As of June 30, 2019 , the Company remains in a net deferred tax asset position. The realization of the Company’s deferred tax assets depends primarily on its ability to generate sufficient U.S. taxable income in future periods. The amount of deferred tax assets considered realizable may increase or decrease in subsequent quarters as management reevaluates the underlying basis for the estimates of future domestic taxable income.

Table of Contents

Notes to Condensed Consolidated Financial Statements (continued)

(Unaudited)

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q. The following discussion and analysis contains forward-looking statements that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. Statements that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are often identified by the use of words such as, but not limited to, “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “seek,” “should,” “target,” “will,” “would” and similar expressions or variations intended to identify forward-looking statements. Such statements include, but are not limited to, statements concerning market opportunity, our future financial and operating results, the consummation of the Merger, investment strategy including the amount of technology investment, sales and marketing strategy, management’s plans, beliefs and objectives for future operations, technology and development, economic and industry trends or trend analysis, expectations about seasonality, opportunities for portfolio purchases, acquisitions, channel partnerships and carrier relationships, use of non-GAAP financial measures, operating expenses, anticipated income tax rates, capital expenditures, cash flows and liquidity. These statements are based on the beliefs and assumptions of our management based on information currently available to us. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified in Part I, Item 1A, “Risk Factors”, of our Annual Report on Form 10-K for the year ended December 31, 2018. Furthermore, such forward-looking statements speak only as of the date of this report. Except as required by law, the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of such events.

Overview

We are a leader in administering Consumer-Directed Benefits (“CDBs”), which empower employees to lower their healthcare related expenditures while also providing corporate tax advantages for employers. We are solely dedicated to administering CDBs, including pre-tax spending accounts such as Health Savings Accounts (“HSAs”), health and dependent care Flexible Spending Accounts (“FSAs”), Health Reimbursement Arrangements (“HRAs”), as well as Commuter Benefit Services, including transit and parking programs, wellness programs, Consolidated Omnibus Budget Reconciliation Act (“COBRA”), and other employee benefits in the United States.

We deliver CDB programs through a highly scalable delivery model that employer clients and their employee participants may access through a standard web browser on any internet-enabled device, including computers, smart phones, and other mobile devices such as tablet computers. Our on-demand delivery model eliminates the need for our employer clients to install and maintain hardware and software in order to support CDB programs and enables us to rapidly implement product enhancements across our entire user base.

Our CDB programs assist employees and their families in saving money by using pre-tax dollars to pay for certain portions of their healthcare, dependent care, and commuter expenses. Employers financially benefit from our programs through reduced payroll taxes, the benefits of which are realized even after factoring in our fees. Under the FSA, HSA, and commuter programs, employee participants contribute funds from their pre-tax income to pay for qualified out-of-pocket healthcare expenses, not fully covered by insurance, such as co-pays, deductibles, and over-the-counter medical products or for commuting costs.

Our services are priced based on the estimated number and types of claims, whether payment processing and client support activities will be provided within or outside of the United States, the estimated number of calls to our customer support center, and any specific client requirements. In addition, we derive a portion of our revenues from interchange fees that we receive when employee participants use the prepaid debit cards we provide to them for healthcare and commuter expenses.

Recent Merger Announcement

On June 26, 2019, the Company entered into a Merger Agreement with HealthEquity and Merger Sub under which HealthEquity will acquire all of the issued and outstanding shares of common stock of the Company for $51.35 per share in cash, representing a total enterprise value of approximately $2 billion. Consummation of the Merger is subject to the satisfaction or waiver of customary closing conditions, including adoption of the Merger Agreement by WageWorks’ stockholders.

Results of Operations

Revenues

Revenues and changes in revenues by product for the three and six months ended June 30, 2019 and 2018 were as follows:



	Three Months Ended June 30,									Six Months Ended June 30,
(In thousands except percentage)	2019		2018		$ Change			% Change		2019		2018		$ Change			% Change
Revenues:
Healthcare	$	65,172	$	68,104	$	(2,932	)	(4	)%	$	137,146	$	143,361	$	(6,215	)	(4	)%
COBRA	20,316		26,200		(5,884		)	(22	)%	43,905		55,035		(11,130		)	(20	)%
Commuter	19,560		18,847		713			4	%	38,900		37,725		1,175			3	%
Other	3,581		3,357		224			7	%	6,903		7,028		(125		)	(2	)%
Total revenues	$	108,629	$	116,508	$	(7,879	)	(7	)%	$	226,854	$	243,149	$	(16,295	)	(7	)%

໿

Healthcare Revenue

We derive our healthcare revenue from the service fees paid by our employer clients for the administration services we provide in connection with their employee participants’ FSAs, HRAs, and HSAs. We also earn interchange revenue paid by financial institutions related to transaction fees on debit cards used by employee participants in connection with all of our healthcare programs and through our wholesale card program and revenue from self-service plan kits called Premium Only Plan kits, or POP revenue.

Healthcare revenue decreased by $2.9 million , or 4% for the three months ended June 30, 2019 , as compared to the same period in 2018 , primarily due to FSA ADP portfolio attrition, partially offset by higher HSA revenue.

Healthcare revenue decreased by $6.2 million , or 4% for the six months ended June 30, 2019 , as compared to the same period in 2018 , primarily due to FSA ADP portfolio attrition, partially offset by higher HSA revenue.

COBRA Revenue

COBRA revenue is derived from administration services we provide to employer clients for continuation of coverage for participants who are no longer eligible for the employer’s health benefits, such as medical, dental, and vision, and for the continued administration of the employee participants’ HRAs and certain healthcare FSAs.

COBRA revenue decreased by $5.9 million , or 22% for the three months ended June 30, 2019 , as compared to the same period in 2018 . The decrease was primarily due to COBRA ADP portfolio attrition, the termination of a key partnership, and generally lower COBRA participant activity.

Table of Contents

COBRA revenue decreased by $11.1 million , or 20% for the six months ended June 30, 2019 , as compared to the same period in 2018 . The decrease was primarily due to COBRA ADP portfolio attrition, the termination of a key partnership, and generally lower COBRA participant activity.

Commuter Revenue

We derive our commuter revenue from monthly service fees paid by our employer clients, interchange revenue paid by financial institutions related to transaction fees on debit cards used by employee participants in connection with our commuter solutions, and commissions from the sale of transit passes used in our commuter solutions which we purchase from various transit agencies on behalf of employee participants.

Commuter revenue increased by $0.7 million , or 4% for the three months ended June 30, 2019 , as compared to the same period in 2018 . The increase s were primarily due to increased transit agency rates and participant usage.

Commuter revenue increased by $1.2 million , or 3% for the six months ended June 30, 2019 , as compared to the same period in 2018 . The increase s were primarily due to increased transit agency rates and participant usage.

Other Revenue

Other revenue includes enrollment and eligibility services, employee account administration (i.e., tuition and health club reimbursements), project-related professional fees and other program incentives.

Other revenue was relatively consistent for the three and six months ended June 30, 2019 , as compared to the same periods in 2018 .

Cost of Revenues



	Three Months Ended June 30,										Six Months Ended June 30,
(In thousands except percentage)	2019			2018			$ Change		% Change		2019			2018			$ Change			% Change
Cost of revenues (excluding amortization of internal use software)	$	36,660		$	36,143		$	517	1	%	$	75,918		$	81,386		$	(5,468	)	(7	)%
Percentage of revenue	34		%	31		%					33		%	33		%

Cost of revenues consists of direct expenses for claims processing, product support, and customer service personnel, outsourced and temporary labor, check/ACH payment processing services, debit card processing services, shipping and handling, passes, and employee participant communications.

Cost of revenues increased by $0.5 million or 1% for the three months ended June 30, 2019 , as compared to the same period in 2018 . The increase was primarily due to higher licensing fees related to our customer relationship management technology.

Cost of revenues decreased by $5.5 million or 7% for the six months ended June 30, 2019 , as compared to the same period in 2018 . The decrease was primarily due to lower outsourced services & printing and fulfillment costs, as well as lower stock-based compensation expense due to the suspension of stock award grants, partially offset by higher technology costs as related to servicing our clients.

Cost of revenues will continue to be affected by our portfolio purchases, acquisitions, and channel partner arrangements. Prior to migrating to our proprietary technology platforms, new portfolios often operate with higher service delivery costs that result in increased cost of revenues until we are able to complete the migration process, which is targeted to occur within 12 to 24 months of the portfolio acquisition date.

Table of Contents

Operating Expenses

Technology and Development



	Three Months Ended June 30,										Six Months Ended June 30,
(In thousands except percentage)	2019			2018			$ Change		% Change		2019			2018			$ Change		% Change
Technology and development	$	15,600		$	13,392		$	2,208	16	%	$	31,940		$	26,425		$	5,515	21	%
Percentage of revenue	14		%	11		%					14		%	11		%

໿

Technology and development expenses consist of personnel and related expenses, outsourced programming services, on-demand technology infrastructure, and expenses associated with equipment and software development and licenses.

Technology and development expenses increased by $2.2 million , or 16% for the three months ended June 30, 2019 , as compared to the same period in 2018 . The increase was primarily due to increased outside services and licensing costs.

Technology and development expenses increased by $5.5 million , or 21% for the six months ended June 30, 2019 , as compared to the same period in 2018 . The increase was primarily due to increased outside services, licensing, technology, and depreciation.

We intend to continue enhancing the functionality of our software platform as part of our continuous effort to improve our employer client and employee participant experience and to maintain and enhance our control and compliance environment. The timing of development and enhancement projects, including the nature of expenditures as well as the phase of the project that could require capitalization or expense treatment, will significantly affect our technology and development expense both in dollar amount and as a percentage of revenues.

Sales and Marketing



	Three Months Ended June 30,											Six Months Ended June 30,
(In thousands except percentage)	2019			2018			$ Change			% Change		2019			2018			$ Change			% Change
Sales and marketing	$	18,269		$	18,521		$	(252	)	(1	)%	$	36,600		$	36,859		$	(259	)	(1	)%
Percentage of revenue	17		%	16		%						16		%	15		%

Sales and marketing expenses consist primarily of compensation and related expenses for our sales, client services, and marketing staff, including sales commissions for our direct sales force and external agent/broker commission expense, as well as communication, promotional, public relations, and other marketing expenses.

Sales and marketing expenses were consistent for the three and six months ended June 30, 2019 , as compared to the same periods in 2018 .

We will continue to invest in sales, client services, and marketing by hiring additional personnel and continuing to build our broker and channel relationships. We will also promote our brand through a variety of marketing and public relations activities.

General and Administrative



	Three Months Ended June 30,										Six Months Ended June 30,
(In thousands except percentage)	2019			2018			$ Change		% Change		2019			2018			$ Change		% Change
General and administrative	$	24,672		$	18,898		$	5,774	31	%	$	52,581		$	44,147		$	8,434	19	%
Percentage of revenue	23		%	16		%					23		%	18		%

General and administrative expenses include personnel and related expenses and professional fees incurred by our executive, finance, legal, human resources, and facilities departments.

Table of Contents

General and administrative expenses increased by $5.8 million or 31% for the three months ended June 30, 2019 , as compared to the same period in 2018 . The increase was primarily due to higher professional fees attributed to excess restatement and audit related costs and merger costs related to the agreement with HealthEquity, partially offset by the reversal of stock-based compensation expense related to performance-based RSUs in the second quarter of 2019.

General and administrative expenses increased by $8.4 million or 19% for the six months ended June 30, 2019 , as compared to the same period in 2018 . The increase was primarily due to higher professional fees attributed to excess restatement costs, and audit related costs and merger costs related to the agreement with HealthEquity, partially offset by the reversal of stock-based compensation expense related to performance-based RSUs in the second quarter of 2019.

Amortization



	Three Months Ended June 30,										Six Months Ended June 30,
(In thousands except percentage)	2019			2018			$ Change		% Change		2019			2018			$ Change		% Change
Amortization	$	11,041		$	10,191		$	850	8	%	$	21,892		$	20,182		$	1,710	8	%
Percentage of revenue	10		%	9		%					10		%	8		%

Our amortization consists of two components: amortization of internal use software and amortization of acquired intangible assets. We capitalize our software development costs related to the development and enhancement of our business solutions. When the technology is available for its intended use, the capitalized costs are amortized over the technology’s estimated useful life, which is generally four years. Acquisition-related intangible assets are also amortized over their estimated useful lives.

Amortization increased by $0.9 million or 8% for the three months ended June 30, 2019 as compared to the same periods in 2018 . The increase was primarily driven by an increase in amortization resulting from internal use software due to increased investment in software development projects.

Amortization increased by $1.7 million or 8% for the six months ended June 30, 2019 as compared to the same periods in 2018 . The increase was primarily driven by an increase in amortization resulting from internal use software due to increased investment in software development projects.

Other Income (Expense), net



	Three Months Ended June 30,										Six Months Ended June 30,
(In thousands except percentage)	2019			2018			$ Change		% Change		2019		2018		$ Change			% Change
Interest and other income, net	$	2,883		$	1,455		$	1,428	98	%	5,532		2,721		$	2,811		103	%
Interest expense	$	(2,164	)	$	(2,420	)	$	256	(11	)%	(4,873	)	(4,602	)	$	(271	)	6	%

Interest and other income increased by $1.4 million or 98% for the three months ended June 30, 2019 . The increase was primarily due to an optimization of cash management and investment practices.

Interest and other income increased by $2.8 million or 103% for the six months ended June 30, 2019 . The increase was primarily due to an optimization of cash management and investment practices.

Interest expense was relatively consistent for the three and six months ended June 30, 2019 as compared to the same periods in 2018 due to lower balances outstanding under the revolving credit facility offset by higher interest rates.

Table of Contents

Income Taxes



	Three Months Ended June 30,										Six Months Ended June 30,
(In thousands except percentage)	2019			2018			$ Change		% Change		2019			2018			$ Change		% Change
Income before income taxes	$	3,106		$	15,545						$	8,582		$	29,416
Income tax provision	$	(1,309	)	$	(4,621	)	$	3,312	(72	)%	$	(2,728	)	$	(7,473	)	$	4,745	(63	)%
Effective tax rate	42		%	30		%					32		%	25		%

Income tax provision decreased by $3.3 million or 72% for the three months ended June 30, 2019 , as compared to the same period in 2018 . The decrease is primarily a result of the tax effect from the reduction of income before tax offset by the impact of increase in the effective tax rate due to increase in state income taxes and discrete impact related to an increase in unrecognized tax benefit recorded in the current period.

Income tax provision decreased by $4.7 million or 63% for the six months ended June 30, 2019 , as compared to the same period in 2018 . The decrease is primarily a result of the tax effect from the reduction of income before tax offset by the impact of increase in the effective tax rate due to increase in state income taxes and discrete impact related to an increase in unrecognized tax benefit recorded.

Table of Contents

Liquidity and Capital Resources

As of June 30, 2019 , our principal sources of liquidity were cash and cash equivalents totaling $807.1 million and short-term investments totaling $160.9 million comprised primarily of funding by clients of amounts to be paid on behalf of employee participants, as well as other cash flows from operating activities.

We believe that our existing cash and cash equivalents, short-term investments, and the available credit from our revolving credit facility will be sufficient to meet our working capital, debt, and capital expenditures, as well as anticipated cash requirements for potential future portfolio purchases over at least the next 12 months. We have historically been able to fulfill our obligations as incurred and expect to continue to fulfill our obligations in the future. Our expectation is based on our current and anticipated client retention rates and our continuing funding model in which the vast majority of our enterprise clients provide us with prefunds as more fully described below under “ Prefunds ”. To the extent these current and anticipated future sources of liquidity are insufficient to fund our future business activities and requirements, including any potential portfolio purchases, we may need to raise additional funds through public or private equity or debt financing. We cannot provide assurance that we will be able to raise additional funds on favorable terms, if at all.

On March 11, 2019, our Board of Directors authorized a $150 million stock repurchase program for 3 years which commenced on March 13, 2019 and expires on March 12, 2022 . Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase programs, or by any combination of such methods. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under its debt obligations and other market and economic conditions. No shares of common stock have been repurchased to date, and future purchases under this program are uncertain at this time.

Prefunds

Under our contracts with the vast majority of our employer clients, we receive prefunds that have been and are expected to continue to be a significant source of cash flows from operating activities. Our client contracts do not contain restrictions on our use of client prefunds and, as a result, each prefund is reflected in cash and cash equivalents on our consolidated balance sheet with an equivalent customer obligation recorded as a liability as the prefund is received. Changes in these prefunds and the corresponding customer obligations are reflected in our cash flows from operating activities. The timing of when employer clients make their prefunds as well as the timing of when we make payments on behalf of employee participants can significantly affect our cash flows.

The operation of these prefunds for our employer clients throughout the year typically is as follows: at the beginning of a plan year, these employer clients provide us with prefunds for their FSA and HRA programs based on a percentage of projected spending by the employee participants for the plan year and other factors. In the case of our commuter program, at the beginning of each month we receive prefunds based on the employee participants’ monthly elections. These prefunds are typically replenished on a weekly basis by our FSA and HRA employer clients and on a monthly basis by our commuter employer clients, in each case, the replenishment occurs after we have advanced the funds necessary to process employee participants’ FSA and HRA claims as they are submitted to us and to pay vendors relating to our commuter programs. As a result, our cash balances can vary significantly depending upon the timing of invoicing and the date payment is received from our employer clients for reimbursement of payments we have made on behalf of employee participants.

Revolving Credit Facility (Credit Agreement)

On April 4, 2017, we entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) with MUFG Union Bank, N.A., as administrative agent (“Agent”). The Credit Agreement amends and restates our existing Amended and Restated Credit Agreement, and increased our borrowing capacity under the revolving credit facility to $400.0 million , with a $15.0 million letter of credit sub-facility. The Credit Agreement contains an increase option permitting us, subject to certain conditions and requirements, to arrange with existing lenders and/or new lenders to provide up to an aggregate of $100.0 million in additional commitments. The principal, together with all accrued and unpaid interest, is due and payable on April 4, 2022. Loan proceeds may be used for general corporate purposes, including acquisitions permitted under the Credit Agreement. We may prepay loans under the Credit Agreement in whole or in part at any time without premium or penalty. The fees incurred in connection with this Credit Agreement are classified as a direct deduction from long-term debt in the condensed consolidated balance sheets. The Second Amended Credit Agreement contains financial and non-financial covenants including debt ratio and interest coverage ratio requirements. The Company is currently in compliance with all the covenants under the credit facility.

In the first quarter of 2019, we entered into a Third Reporting Extension Agreement and paid the Agent $0.1 million to extend the delivery date of the 2018 Annual Report on Form 10-K to May 10, 2019. In the second quarter of 2019, we entered into a

Table of Contents

Fourth Reporting Extension Agreement and paid the Agent $0.1 million to extend the delivery date of the 2018 Annual Report on Form 10-K to May 31, 2019. The fees incurred were added to loan financing fees to be amortized to interest expense over the remaining life of the loan. In the year to date period ended June 30, 2019, we paid down $100.0 million of the outstanding revolving credit facility balance, and plan to continue to make payments on this balance throughout 2019.

As of June 30, 2019 , we had $147.0 million outstanding under the revolving credit facility and $250.2 million unused revolving credit facility still available to borrow under the Credit Agreement. As of June 30, 2019 , the interest rate applicable to the revolving credit facility was 3.90% per annum.

Cash Flows

The following table presents information regarding our cash flow activities:



	Six Months Ended June 30,
(in thousands)	2019			2018			$ Change
Net cash (used in) provided by operating activities	$	(44,192	)	$	13,559		$	(57,751	)
Net cash provided by (used in) investing activities	52,492			(82,105		)	134,597
Net cash (used in) provided by financing activities	(99,931		)	1,395			(101,326		)
Net change in cash and cash equivalents, unrestricted and restricted	$	(91,631	)	$	(67,151	)	$	(24,480	)

Cash Flows from Operating Activities

໿

Net cash used in operating activities increased for the six months ended June 30, 2019 as compared to the same period of 2018 by $57.8 million . The increase in cash used in operating activities for the six months ended June 30, 2019 was primarily due to changes in working capital largely driven by timing of employer client terminations and employer client payments.

Cash Flows from Investing Activities

໿

Net cash provided by investing activities was $52.5 million for the six months ended June 30, 2019 , primarily due to $62.2 million of net proceeds from sales and purchases of investments, offset by $9.7 million of investment in capital expenditures.

Net cash used in investing activities was $82.1 million for the six months ended June 30, 2018 , primarily due to $62.1 million net purchases of investments and $19.8 million of investment in capital expenditures.

Cash Flows from Financing Activities

໿

Net cash used in financing activities was $99.9 million for the six months ended June 30, 2019 , primarily due to a repayment of debt principal of $100.0 million .

Net cash provided by financing activities was $1.4 million for the six months ended June 30, 2018 which consisted of approximately $2.3 million in proceeds from exercises of stock options and sale of stock under the 2012 Employee Stock Purchase Plan, partially offset by a $0.2 million payment of taxes related to net share settlement of stock-based compensation arrangements.

Contractual Obligations

During the second quarter of 2019, the Company entered into an approximately 10-year lease agreement with Union Mesa 1, LLC to occupy 150,000 square feet of new office space in Mesa, AZ. The base rent obligation is expected to commence in the third quarter of 2020. In addition to the base rent payments, the Company will be obligated to pay certain customary amounts for its share of operating expenses and tax obligation. The Company has the option to extend the term of the lease for two additional five-year periods. Contractual obligations related to this lease are shown in the table below (in thousands):



	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years
Future lease obligation (Mesa)	$	63,094	$	—	$	5,803	$	11,944	$	45,347

Other than the changes described above, there were no material changes, outside of the ordinary course of business, in our contractual obligations from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2018 .

Table of Contents

Critical Accounting Policies and Significant Management Estimates

There have been no material changes to the Company’s critical accounting estimates during the three and six months ended June 30, 2019 . Other than the adoption of ASU 2016-02, “Leases (Topic 842)” , there have been no material changes to the Company’s critical accounting policies during the three and six months ended June 30, 2019 compared to the policies disclosed in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Annual Report on Form 10-K for the year ended December 31, 2018 .

Off-Balance Sheet Arrangements

Other than outstanding letters of credit issued under our revolving credit facility, we do not have any off-balance sheet arrangements. The majority of the standby letters of credit expire in one year. However, in the ordinary course of business, we will continue to renew or modify the terms of the letters of credit to support business requirements. The letters of credit are contingent liabilities, supported by our revolving credit facility, and are not reflected on our condensed consolidated balance sheets.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in the Company’s market risk during the six months ended June 30, 2019 . For additional information, see Part II, Item 7A., “Quantitative and Qualitative Disclosures About Market Risk”, of our Annual Report on Form 10-K for the year ended December 31, 2018 .

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures.

We have, with the participation of our Chief Executive Officer (CEO) and our Chief Financial Officer (CFO), evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2019 . The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms.

Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Based on the evaluation of our disclosure controls and procedures as of June 30, 2019 , our CEO and CFO concluded that, as of such date, due to the identification of material weaknesses in our internal control over financial reporting, as further described in our 2018 Form 10-K, our disclosure controls and procedures were not effective. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

Notwithstanding the material weaknesses in our internal control over financial reporting reported in the Form 10-K for the fiscal year ended December 31, 2018, we have concluded that the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with accounting principles generally accepted in the United States of America.

Additional Analyses and Procedures and Remediation Plan

We have begun remediating the material weaknesses identified by management and described in greater detail in our 2018 Form 10-K. Although we intend to complete the remediation process with respect to this material weaknesses as quickly as possible, we cannot at this time estimate how long it will take, and our remediation plan may not prove to be successful.

Because the reliability of the internal control process requires repeatable execution, the successful remediation of the company’s material weaknesses will require review and evidence of effectiveness prior to concluding that the controls are effective, and there is no assurance that additional remediation steps will not be necessary. As such, as we continue to evaluate and work to improve our internal control over financial reporting, our management may decide to take additional measures to address the material weaknesses or modify the remediation steps already underway. As noted above, although we plan to complete the remediation

Table of Contents

process as quickly as possible, we cannot at this time estimate how long it will take, and our initiatives may not prove to be successful. Accordingly, until this weakness is remediated, we are performing additional analyses and other procedures to ensure that our condensed consolidated financial statements are prepared in accordance with GAAP.

Changes in Internal Control Over Financial Reporting

Our remediation efforts were ongoing during the period of the report. During 2019, the Company has filled certain key leadership roles in Accounting and Risk Management and is in the process of enhancing capabilities of that department. The Company has engaged Senior Leadership across the various departments of the organization to have ownership of areas of controls and remediation. Performance measurement metrics across various levels of the organization have also incorporated controls remediation as a key element. In addition, an outside service provider has been engaged to assist with the remediation efforts in the areas of identified weaknesses.

In order to remediate our existing material weaknesses, we require additional time to complete the implementation of our remediation plans and demonstrate the effectiveness of our remediation efforts. The material weaknesses cannot be considered remediated until the applicable remedial controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

Other than the remediation efforts outlined above, there were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the year-to-date period ended June 30, 2019 , that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

Information with respect to this Item may be found under the heading “Legal Matters” in Note 10 to the Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which is incorporated into this Item 1 by reference.

Item 1A. Risk Factors

Except as set forth below, there have been no material changes in our risk factors disclosed in Part I, Item 1A, “Risk Factors”, of our Annual Report on Form 10-K for the year ended December 31, 2018 .

The announcement and pendency of our agreement to be acquired by HealthEquity could adversely affect our business.

On June 26, 2019, we entered into the Merger Agreement to be acquired by HealthEquity. Uncertainty about the effect of the Merger on our customers, employees, partners and other parties may adversely affect our business. Our employees may experience uncertainty about their roles or seniority following the closing of the Merger and the Merger could adversely affect our ability to attract and retain employees. Any loss or distraction of such employees could adversely affect our business and operations. In addition, we have diverted, and will continue to divert, significant management resources toward the completion of the Merger, which could adversely affect our business and operations. Parties with which we do business may experience uncertainty associated with the Merger, including with respect to current or future business relationships with us. Uncertainty may cause customers to refrain from doing business with us, which could adversely affect our business, results of operations and financial condition.

The failure to complete the Merger with HealthEquity in a timely manner or at all could adversely affect our business.

Consummation of the Merger with HealthEquity is subject to several conditions beyond our control that may prevent, delay, or otherwise adversely affect its completion. If any of these conditions are not satisfied or waived, it is possible that the Merger will not be consummated in the expected time frame (or at all) or that the Merger Agreement may be terminated. In the event that the Merger is not completed for any reason, the holders of our common stock will not receive any payment for their shares of common stock in connection with the proposed Merger. Instead, we will remain an independent public company and the holders of our common stock will continue to own their shares of common stock. If the Merger is not completed, the share price of our common stock may decrease to the extent that the current market price of our common stock reflects an assumption that the Merger will be completed. In addition, under circumstances specified in the Merger Agreement, we may be required to pay a termination fee of approximately $69.7 million to HealthEquity which could adversely affect our business, results of operations and financial condition including our cash flows.

While the Merger is pending, we are subject to business uncertainties and contractual restrictions that could harm our operations and the future of our business or result in a loss of employees.

Pursuant to the terms of the Merger Agreement, we are subject to certain customary restrictions on the conduct of our business. These restrictions generally require us to conduct our businesses in the ordinary course, consistent with past practice, and subject us to a variety of specified limitations, including the ability in certain cases to enter into material contracts, acquire or dispose of assets, repurchase shares of our capital stock, incur indebtedness or incur capital expenditures, until the Merger becomes effective or the Merger Agreement terminates. These restrictions, which are standard for a transaction of this type, may inhibit our ability to take actions outside of the ordinary course of our business that are inconsistent with our past practice but which we may consider advantageous and limit our ability to respond to future business opportunities and industry developments that may arise during such period. Our customers, employees, partners and other parties may have uncertainties about the effects of the Merger. In connection with the Merger, it is possible that some customers and other persons with whom we have a business relationship may delay or defer certain business decisions or might decide to seek to terminate, change or renegotiate their relationship with us as a result of the Merger. If any of these effects were to occur, it could materially and adversely impact our revenue, earnings, cash flows and other business results and our financial condition, as well as the market price of our common stock and our perceived acquisition value, regardless of whether the Merger is completed. In addition, while the Merger is pending we will continue to incur costs, fees, expenses and charges related to the Merger, which may materially and adversely affect our financial condition.

The Merger Agreement limits our ability to pursue alternatives to the Merger.

The Merger Agreement contains provisions that make it more difficult for us to enter into alternative transactions. For example, the Merger Agreement contains certain provisions that restrict our ability to, among other things, solicit, initiate or knowingly facilitate or encourage the submission of any inquiry, discussion, offer, proposal or request that could constitute, or could reasonably

Table of Contents

be expected to lead to, an acquisition proposal from a third party. The Merger Agreement also provides that our Board of Directors will not change its recommendation that our stockholders adopt the Merger Agreement and will not approve or recommend any agreement with respect to an acquisition proposal from a third party.

Litigation may arise in connection with the Merger, which could be costly and divert management’s attention and otherwise materially harm our business.

Lawsuits may be filed challenging the disclosures contained in the proxy statement and/or challenging other aspects of the Merger. Regardless of the outcome of any future litigation related to the Merger, such litigation may be time-consuming and expensive and may distract our management from running the day-to-day operations of our business. The litigation costs and diversion of management’s attention and resources to address the claims and counterclaims in any litigation related to the Merger may materially adversely affect our business, financial condition and operating results. Litigation related to the Merger may result in negative publicity or an unfavorable impression of us, which could adversely affect the price of our common stock, impair our ability to recruit or retain employees, damage our relationships with our customers and suppliers, or otherwise materially harm our operations and financial performance.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Stock Repurchases

None

Unregistered Sales of Equity Securities

On May 20, 2019, a former member of the Board of Directors exercised an option to purchase 17,000 shares of common stock of the Company (the “Shares”). The average exercise price for the Shares was $18.58 for a total aggregate exercise price of $315,830.

Item 4. Mine Safety Disclosures

Not Applicable

Item 5. Other Information

The terms of the Class III directors consisting of Stuart C. Harvey, Jr., Thomas A. Bevilacqua and Bruce G. Bodaken were to have expired at the Annual Meeting of Stockholders in 2018 and the terms of the Class I directors consisting of Jerome D. Gramglia, Robert L. Metzger and George P. Scanlon were to have expired at the Annual Meeting of Stockholders in 2019. However, the Company has not convened an Annual Meeting of Stockholders since 2017, and, consequently, the terms of the Class III and Class I directors will expire at the Company’s next Annual Meeting of Stockholders.

Bonus Payment to Ismail (Izzy) Dawood

In April 2019, our Board of Directors, with input from the Compensation Committee, approved a bonus payment to Mr. Dawood of $150,000 for 2018 performance after considering the pro-rated target bonus opportunity for Mr. Dawood for 2018 under his offer letter and his and the Company’s 2018 performance, including his extraordinary leadership in guiding our finance team to completing the filings relating to our restatement.

Mesa Office Lease



	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years
Future lease obligation (Mesa)	$	63,094	$	—	$	5,803	$	11,944	$	45,347

Table of Contents

Item 6. Exhibits



		Incorporated by Reference
Exhibit No.	Exhibit Description	Form	File No.	Exhibit	Filing Date	Filed Herewith
2.1(2)	Agreement and Plan of Merger, dated as of June 26, 2019, by and among HealthEquity, Inc., Pacific Merger Sub Inc. and WageWorks, Inc.	8-K	001-35232	2.1	6/27/2019
3.10	Amended and Restated Bylaws of WageWorks, Inc.	8-K	001-35232	3.1	6/27/2019
10.10H	Second Amended and Restated Credit Agreement, by and among Registrant, MUFG Union Bank, N.A. (formerly Union Bank, N.A.), Wells Fargo Bank National Association, Suntrust Bank, UMB Bank, N.A., KeyBank National Association, and Comerica Bank dated June 5, 2015	10-Q	001-35232	10.10H	8/1/2017
10.30	Form of Change in Control and Severance Agreement	10-K	001-35232	10.30	5/30/2019
10.35	Dawood Offer Letter	10-Q	001-35232	10.35	6/27/2019
10.36	Lease Agreement between Union Mesa 1, LLC and Registrant dated June 11, 2019					X
10.37	Reporting Extension Agreement and Waiver, dated as of May 9, 2019, by and among WageWorks, Inc., the lenders party thereto and MUFG Union Bank, N.A., as administrative agent	8-K	001-35232	10.1	5/10/2019
31.1	Certification of the Principal Executive Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002					X
31.2	Certification of the Principal Financial Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002					X
32.1 ⁽¹⁾	Certification of the Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002					X
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Schema Linkbase Document
101.CAL	Inline XBRL Taxonomy Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Labels Linkbase Document
101.PRE	Inline XBRL Taxonomy Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)					X

(1)

The certifications attached as Exhibit 32.1 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of WageWorks, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-Q, irrespective of any general incorporation language contained in such filing.


(2)	Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K, but a copy will be furnished supplementally to the Securities and Exchange Commission upon request.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



		WAGEWORKS, INC.

Date: August 8, 2019	By:	/s/ ISMAIL DAWOOD
		Ismail Dawood
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

Wageworks (NYSE:WAGE)
Historical Stock Chart
From Oct 2024 to Nov 2024

Wageworks (NYSE:WAGE)
Historical Stock Chart
From Nov 2023 to Nov 2024

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

WAGE Wageworks Inc

Latest WAGE Messages

Loading Messages....

Wageworks, Inc. News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

WAGE Wageworks Inc

Latest WAGE Messages

Loading Messages....

Wageworks, Inc. News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App